Researchers have identified a novel molecule that effectively halts the progression of triple-negative breast cancer (TNBC), an aggressive and difficult-to-treat form of the disease. The molecule works by targeting a specific protein pathway that drives the cancer’s growth and metastasis. In laboratory studies using human cells and animal models, the treatment caused cancer cells to stop proliferating and eventually die, without harming healthy cells. This discovery offers a promising new direction for developing targeted therapies for TNBC, which currently has limited treatment options and a poorer prognosis. The full findings are detailed in the source article: https://www.sciencedaily.com/releases/2026/03/260309225146.htm